Stacie Lindsey, CEO at Cholangiocarcinoma Foundation, shared on LinkedIn:
“The Cholangiocarcinoma Foundation team was pleased to host an informative webinar with industry partners AstraZeneca, Compass Therapeutics Inc., Incyte, Jazz Pharmaceuticals, J-Pharma, Partner Therapeutics, and Taiho Oncology, Inc. Information on the latest clinical trials and treatments was shared with patients and their families and Juan W. Valle, MB ChB MSc FRCP provided an update on emerging research findings that were presented at American Society of Clinical Oncology (ASCO).
If you weren’t able to make it, you can view the recording here.
Keeping patients informed of their options is part of our mission, and we are grateful for the partners who help make that possible.”
Other articles featuring Stacie Lindsey on OncoDaily.